Literature DB >> 12725686

The complex relationship between respiratory syncytial virus and allergy in lung disease.

R Stokes Peebles1, Koichi Hashimoto, Barney S Graham.   

Abstract

Epidemiologic studies suggest a strong link between severe respiratory syncytial virus (RSV)-induced bronchiolitis in infancy and allergic disease; however, the mechanisms determining this relationship are currently unknown. In this review article, we summarize data from human clinical studies that explore the association between RSV infection and allergy, some that suggest that RSV bronchiolitis requiring hospitalization leads to an increased incidence of the allergic phenotype and others that suggest that pre-existing allergy is a risk factor for severe RSV bronchiolitis. We also review the published murine models that combine RSV infection and allergic sensitization that attempt to explain the complex relationship between these two factors in regard to lung immunopathology and physiologic dysfunction.

Entities:  

Mesh:

Year:  2003        PMID: 12725686     DOI: 10.1089/088282403763635429

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  8 in total

Review 1.  Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

2.  Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

Authors:  Nicholas W Lukacs; Martin L Moore; Brian D Rudd; Aaron A Berlin; Robert D Collins; Sandra J Olson; Samuel B Ho; R Stokes Peebles
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

3.  T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection.

Authors:  Padma Billam; Kathryn L Bonaparte; Jie Liu; Tracy J Ruckwardt; Man Chen; Alex B Ryder; Rui Wang; Pradyot Dash; Paul G Thomas; Barney S Graham
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

4.  Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.

Authors:  Asunción Mejías; Susana Chávez-Bueno; Ana María Ríos; Jesús Saavedra-Lozano; Mónica Fonseca Aten; Jeanine Hatfield; Payal Kapur; Ana María Gómez; Hasan S Jafri; Octavio Ramilo
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

5.  Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV.

Authors:  Teresa R Johnson; Steven M Varga; Thomas J Braciale; Barney S Graham
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse.

Authors:  Weisong Zhou; Koichi Hashimoto; Martin L Moore; Jack A Elias; Zhou Zhu; Joan Durbin; Giuseppe Colasurdo; John A Rutigliano; Constance L Chiappetta; Kasia Goleniewska; Jamye F O'Neal; Barney S Graham; R Stokes Peebles
Journal:  Microbes Infect       Date:  2006-10-24       Impact factor: 2.700

7.  Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.

Authors:  S Tourdot; S Mathie; T Hussell; L Edwards; H Wang; P J M Openshaw; J Schwarze; C M Lloyd
Journal:  Clin Exp Allergy       Date:  2008-06       Impact factor: 5.018

8.  Respiratory syncytial virus infection: from biology to therapy: a perspective.

Authors:  Shyam S Mohapatra; Richard F Lockey
Journal:  World Allergy Organ J       Date:  2008-02       Impact factor: 4.084

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.